Search Results - "abu Salach, O"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Comparative pharmacokinetic and pharmacodynamic analysis of phthaloyl glycine derivatives with potential antiepileptic activity by abu Salach, O, Hadad, S, Haj-Yehia, A, Sussan, S, Bialer, M

    Published in Pharmaceutical research (01-10-1994)
    “…Glycine, in addition to GABA, is one of the most important neurotransmitter amino acids. The described structure pharmacokinetic pharmacodynamic relationships…”
    Get full text
    Journal Article
  2. 2

    Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations by Bialer, M, Sussan, S, Abu Salach, O, Danenberg, H D, Ben-David, J, Gibor, Y, Laor, A

    Published in Journal of pharmaceutical sciences (01-10-1995)
    “…The three classical pharmacokinetic parameters used to assess bioequivalence, AUC (total area from zero to infinity), Cmax (peak plasma concentration), and…”
    Get more information
    Journal Article
  3. 3

    Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment by Bialer, M, Hadad, S, Golomb, G, Barel, S, Samara, E, Abu Salach, O, Berkman, N, Danenberg, H D, Ben David, J, Caron, D

    Published in Biopharmaceutics & drug disposition (01-01-1994)
    “…The pharmacokinetics of two new sustained-release (SR) products of diltiazem, Dilapress 120 mg tablets and Dilapress 240 mg tablets, was analysed and…”
    Get more information
    Journal Article